Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.68M Hold
20,042
0.27% 67
2025
Q2
$1.63M Sell
20,042
-3,009
-13% -$239K 0.27% 69
2025
Q1
$2.07M Buy
23,051
+15,088
+189% +$1.41M 0.45% 50
2024
Q4
$804K Sell
7,963
-610
-7% -$62.9K 0.17% 99
2024
Q3
$930K Buy
+8,573
New +$1.02M 0.2% 88
2024
Q1
$777K Buy
+6,042
New +$745K 0.24% 80

Other funds holding MRK

Watts Gwilliam & Co's MRK Position: Q3 2025 in Review

Watts Gwilliam & Co held its Merck (MRK) position steady in Q3 2025 at 20,042 shares worth $1.68M. The position accounts for 0.27% of the portfolio, ranked #67.

Watts Gwilliam & Co first reported a position in MRK in Q1 2024 and has held it in 6 quarters since. The position peaked at $2.07M in Q1 2025. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.

  • Watts Gwilliam & Co held 20,042 shares of Merck worth $1.68M as of Q3 2025.
  • Watts Gwilliam & Co left its Merck share count unchanged in Q3 2025.
  • Merck made up 0.27% of Watts Gwilliam & Co's portfolio in Q3 2025, its #67 holding.
  • Watts Gwilliam & Co first reported a position in Merck in Q1 2024 and has held it in 6 quarters since.
  • Watts Gwilliam & Co's Merck position peaked at $2.07M in Q1 2025.
  • 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.

Based on Watts Gwilliam & Co's 13F filing for Q3 2025, filed 21 Nov 2025.